Literature DB >> 6728040

Estimation of intrasynaptic norepinephrine concentrations at vascular neuroeffector junctions in vivo.

I J Kopin, Z Zukowska-Grojec, M A Bayorh, D S Goldstein.   

Abstract

We estimated vascular neuroeffector junctional norepinephrine concentrations and their relation to pressor responses by measuring plasma norepinephrine levels and blood pressure during sympathetic stimulation or norepinephrine infusion in pithed, vagotomized, alpha 2-adrenoceptor blocked, adrenal-demedullated rats with and without uptake1 blockade by desipramine. For an increment in mean arterial pressure of 50 mm Hg, the estimated mean junctional norepinephrine concentration ( ES50m ) was about 7 nmol/l. Norepinephrine concentration gradients between the site of norepinephrine release and plasma appeared to be equal and reciprocal for sympathetic stimulation and for norepinephrine infusion. These gradients were reduced equally (by about two-thirds) after desipramine treatment, indicating that removal of both released and infused norepinephrine is mainly by neuronal uptake.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6728040     DOI: 10.1007/BF00504372

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  17 in total

1.  Assay of cathecholamines in human plasma: studies of a single isotope radioenzymatic procedure.

Authors:  V K Weise; I J Kopin
Journal:  Life Sci       Date:  1976-12-01       Impact factor: 5.037

2.  Uptake and re-use of sympathetic transmitter in the cat's spleen.

Authors:  A G Blakeley; L Brown; L B Geffen
Journal:  Proc R Soc Lond B Biol Sci       Date:  1969-10-07

3.  A method of stimulating the complete sympathetic outflow from the spinal cord to blood vessels in the pithed rat.

Authors:  J S Gillespie; T C Muir
Journal:  Br J Pharmacol Chemother       Date:  1967-05

4.  The influence of desipramine on the sensitivity and accumulation of noradrenaline in the isolated tail artery of the rat.

Authors:  A Bonaccorsi; J Jespersen; S Garattini
Journal:  Eur J Pharmacol       Date:  1970-01       Impact factor: 4.432

5.  The origin of the decline in the vasopressor response to infused noradrenaline in the pithed rat.

Authors:  J S Gillespie; T C Muir
Journal:  Br J Pharmacol Chemother       Date:  1967-05

6.  Site of action of cocaine on the perfused artery.

Authors:  I S De La Lande; J G Waterson
Journal:  Nature       Date:  1967-04-15       Impact factor: 49.962

7.  The influence of sympathetic innervation on vascular sensitivity to noradrenaline.

Authors:  I S De la Lande; D Frewin; J G Waterson
Journal:  Br J Pharmacol Chemother       Date:  1967-09

8.  Effect of desipramine on the effects of alpha-adrenoceptor inhibitors on pressor responses and release of norepinephrine into plasma of pithed rats.

Authors:  Z Zukowska-Grojec; M A Bayorh; I J Kopin
Journal:  J Cardiovasc Pharmacol       Date:  1983 Mar-Apr       Impact factor: 3.105

9.  THE UPTAKE OF NORADRENALINE BY THE ISOLATED PERFUSED RAT HEART.

Authors:  L L IVERSEN
Journal:  Br J Pharmacol Chemother       Date:  1963-12

Review 10.  Evidence for more than one type of post-junctional alpha-adrenoceptor.

Authors:  J C McGrath
Journal:  Biochem Pharmacol       Date:  1982-02-15       Impact factor: 5.858

View more
  17 in total

1.  Estimation of the biophase concentration of noradrenaline at presynaptic alpha 2-adrenoceptors in brain slices.

Authors:  C Allgaier; E Agneter; T J Feuerstein; E A Singer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-04       Impact factor: 3.000

2.  Disposition of endogenous adrenaline compared to noradrenaline released by cardiac sympathetic nerves in the anaesthetized dog.

Authors:  G Eisenhofer; J J Smolich; M D Esler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-02       Impact factor: 3.000

3.  A vesicular sequestration to oxidative deamination shift in myocardial sympathetic nerves in Parkinson's disease.

Authors:  David S Goldstein; Patricia Sullivan; Courtney Holmes; Gary W Miller; Yehonatan Sharabi; Irwin J Kopin
Journal:  J Neurochem       Date:  2014-06-13       Impact factor: 5.372

4.  Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans.

Authors:  D S Goldstein; G Eisenhofer; R Stull; C J Folio; H R Keiser; I J Kopin
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

5.  The role of extraneuronal amine transport systems for the removal of extracellular catecholamines in the rabbit.

Authors:  B Friedgen; R Wölfel; H Russ; E Schömig; K H Graefe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

6.  Enhancement of in vitro growth of pathogenic bacteria by norepinephrine: importance of inoculum density and role of transferrin.

Authors:  Phyllis M O'Donnell; Hernan Aviles; Mark Lyte; Gerald Sonnenfeld
Journal:  Appl Environ Microbiol       Date:  2006-07       Impact factor: 4.792

7.  Effects of catechol-O-methyltransferase inhibition on the plasma clearance of noradrenaline and the formation of 3,4-dihydroxyphenylglycol in the rabbit.

Authors:  T Halbrügge; B Friedgen; J Ludwig; K H Graefe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-02       Impact factor: 3.000

8.  Measurement of regional neuronal removal of norepinephrine in man.

Authors:  D S Goldstein; R Zimlichman; R Stull; J Folio; P D Levinson; H R Keiser; I J Kopin
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

9.  Total body, systemic and pulmonary clearance and fractional extraction of unlabelled and differently 3H-labelled noradrenaline in the anaesthetized rabbit.

Authors:  T Halbrügge; A L Ungell; R Wölfel; K H Graefe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-10       Impact factor: 3.000

10.  The measurement of norepinephrine clearance and spillover rate into plasma in conscious spontaneously hypertensive rats.

Authors:  T K Keeton; A M Biediger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-10       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.